GMED P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
GMED's p/e ratio is lower than 95% of the last 10 years.
P/E ratio History
GMED P/E ratio by year
Yearly range of GMED’s p/e ratio from 2016 to 2026. Over the full period it ranged from 16.9 to 249.6, averaging 47.2.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 17.6 | 21.2 | 24.7 | 19.3 |
| 2025 | 18.2 | 50.1 | 124.9 | 22.3 |
| 2024 | 43.8 | 124.6 | 249.6 | 110.7 |
| 2023 | 24.4 | 30.7 | 42.8 | 34.4 |
| 2022 | 37.1 | 45.6 | 59.8 | 49.2 |
| 2021 | 34.6 | 51.7 | 67.7 | 50.5 |
| 2020 | 22.9 | 47.2 | 71.6 | 65.2 |
| 2019 | 24.7 | 32.5 | 41.0 | 38.5 |
| 2018 | 28.1 | 40.2 | 48.2 | 28.1 |
| 2017 | 23.0 | 28.4 | 37.9 | 37.4 |
| 2016 | 16.9 | 18.6 | 20.4 | 20.3 |
Get notified when GMED P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is GMED P/E ratio High or Low Right Now?
Globus Medical, Inc.'s P/E ratio is currently 19.3, which is near historic low relative to its 10-year historical range. The 10-year median P/E ratio for GMED is approximately 37.2. See all GMED valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.